SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,997,000 | +47.3% | 23,525 | 0.0% | 2.36% | +101.0% |
Q1 2020 | $2,714,000 | +2.0% | 23,525 | +1.0% | 1.18% | +24.6% |
Q4 2019 | $2,661,000 | +34.5% | 23,290 | +0.5% | 0.94% | -13.7% |
Q3 2019 | $1,979,000 | +59.0% | 23,170 | +28.8% | 1.09% | +123.3% |
Q2 2019 | $1,245,000 | +2.9% | 17,985 | +8.8% | 0.49% | +9.6% |
Q1 2019 | $1,210,000 | +29.3% | 16,524 | 0.0% | 0.45% | -60.7% |
Q4 2018 | $936,000 | -47.3% | 16,524 | -28.2% | 1.14% | -62.1% |
Q3 2018 | $1,776,000 | +61.9% | 23,027 | +39.4% | 3.00% | +71.0% |
Q2 2018 | $1,097,000 | -6.2% | 16,524 | -26.0% | 1.76% | +277.6% |
Q1 2018 | $1,169,000 | +6.1% | 22,334 | +8.4% | 0.46% | -13.6% |
Q4 2017 | $1,102,000 | -1.7% | 20,603 | 0.0% | 0.54% | -53.2% |
Q3 2017 | $1,121,000 | +10.3% | 20,603 | +4.9% | 1.15% | -14.7% |
Q2 2017 | $1,016,000 | +151.5% | 19,634 | +205.2% | 1.35% | +301.2% |
Q1 2017 | $404,000 | -65.3% | 6,433 | -70.8% | 0.34% | -43.7% |
Q4 2016 | $1,163,000 | +386.6% | 22,045 | +397.4% | 0.60% | +2495.7% |
Q3 2016 | $239,000 | – | 4,432 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |